PRAVALIP 10

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
PRAVASTATIN SODIUM
Available from:
UNIPHARM LTD, ISRAEL
ATC code:
C10AA03
Pharmaceutical form:
TABLETS
Composition:
PRAVASTATIN SODIUM 10 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL
Therapeutic group:
PRAVASTATIN
Therapeutic area:
PRAVASTATIN
Therapeutic indications:
Pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . Pravastatin should be used in addition to a diet and other nonpharmacological measures alone has been inadequate. Primary prevention of coronary events: In hypercholesterolemic patients wihthout clinically evident coronary heart disease pravastatin is indicated to: 1) Reduce the risk of myocardial infarcton. 2) Reduce the risk for revascularization. 3) Reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes. Secondary prevention of cardiovascular events: a) Atherosclerosis: In hypercholesterolemic patients with clinically evident coronary artery disease including prior MI pravastatin is indicated to: 1)Slow the progression of coronary atherosclerosis. 2) Reduce the risk of acute coronary events. b) Myocardial infarction: in patients with previous
Authorization number:
132 80 31134 00
Authorization date:
2010-03-31

Documents in other languages

Patient Information leaflet Patient Information leaflet - Arabic

16-08-2020

Patient Information leaflet Patient Information leaflet - Arabic

17-01-2021

PATIENT PACKAGE INSERT IN

ACCORDANCE WITH THE PHARMACISTS’

REGULATIONS )PREPARATIONS( – 1986

The medicine is dispensed

with a doctor’s prescription only

Pravalip 10; 20; 40

Tablets

Composition:

Each Pravalip 10 tablet contains:

Pravastatin sodium 10 mg

Each Pravalip 20 tablet contains:

Pravastatin sodium 20 mg

Each Pravalip 40 tablet contains:

Pravastatin sodium 40 mg

For the list of inactive ingredients, please see

section 6.

Read this leaflet carefully in its entirety

before using the medicine. This leaflet

contains concise information about the

medicine. If you have further questions, refer

to the doctor or pharmacist.

This medicine has been prescribed to treat

your ailment. Do not pass it on to others. It

may harm them, even if it seems to you that

their ailment is similar.

This medicine is not intended for use in

children and adolescents under 18 years of

age.

Therapeutic group: Pravastatin belongs to

a group of medicines called “statins”. Statins

inhibit the activity of the HMG-CoA reductase

enzyme.

1. WHAT IS THE MEDICINE INTENDED FOR?

Reduction

cholesterol,

LDL-C

triglyceride levels, and increase in HDL-C

levels. In hypercholesterolemic patients

and with no evidence of coronary disease,

pravastatin reduces the risk of myocardial

infarction and extends the life expectancy.

patients

with

atherosclerosis

average )normal( or high cholesterol level,

pravastatin reduces the risk of overall mortality

and of mortality due to heart diseases,

and reduces the risk of heart attack; in

hypercholesterolemic patients, pravastatin

reduces the risk of angina pectoris.

2. BEFORE uSING THE MEDICINE

Do not use the preparation if:

you are pregnant, planning to become

pregnant or are breastfeeding.

you are sensitive )allergic( to pravastatin

or to any of the additional ingredients

contained in the medicine )listed in section

you are suffering from active liver disease

or from unexplained, persistent elevations

in liver function test results.

119108010

03D20

Special warnings regarding use of this

medicine:

This preparation contains lactose and may

cause an allergic reaction in people sensitive

to lactose.

Before

treatment

with

this

medicine,

cholesterol and liver function tests should be

performed. Repeat tests will be performed

as needed.

Tell the doctor if you experience prolonged

muscle weakness during the course of

treatment with the medicine. You may need

additional tests and medicines to diagnose

and treat the problem.

If you are sensitive to any food or medicine,

inform the doctor before taking the medicine.

If you become pregnant during the course of

treatment with this medicine, stop treatment

and refer to a doctor immediately.

Consult the doctor regarding use of

appropriate contraceptives during the

course of treatment with this medicine.

There have been reports of cognitive effects

)e.g., memory loss, confusion( arising from

use of medicines from the statin group.

These effects were mild and passed after

discontinuing use of the medicines.

If you are over the age of 70, perform a

blood test before starting the treatment,

and occasionally even during the treatment,

to assess the risk of muscle-related side

effects.

Use of this medicine may cause an increase

of blood sugar levels. Likewise, the use may

increase the risk of developing diabetes in

patients with an increased risk of developing

diabetes )high fasting blood sugar level ]5.6-

6.9 mmol/L[(, hypertension, high triglyceride

levels, obesity )BMI>30 kg/m

(. In these

patients, a doctor’s monitoring and periodic

blood tests are necessary throughout the

course of treatment with the medicine.

Before beginning treatment with

Pravalip, tell the doctor if you are suffering

from the following effects:

If you are suffering, or have suffered in the

past, from impaired function of the liver or

kidney

An underactive thyroid )hypothyroidism(

Severe respiratory failure

Uncontrolled seizures

If you are due to undergo, or have recently

undergone, major surgery

If you consume large amounts of alcoholic

beverages

If you or a member of your family suffers

from a hereditary muscle disorder or if you

have suffered from muscle problems while

taking other lipid-lowering medicines from

the statin or fibrate groups.

If you are taking, or have recently

taken, other medicines, including non-

prescription medicines or nutritional

supplements, tell the doctor or pharmacist.

Especially if you are taking:

Ciclosporin )to suppress the immune

system(

Medicines from the fibrate group to

lower cholesterol level )e.g., gemfibrozil,

fenofibrate(

Nicotinic acid )niacin(

A n t i b i o t i c s

) e . g . ,

e r y t h r o m y c i n ,

clarithromycin(

Re s i n - b i n d i n g - t y p e

l i p i d - l o w e r i n g

medicines, such as cholestyramine and

colestipol. Take Pravalip at least one hour

before or four hours after taking resin-

binding medicines such as cholestyramine

or colestipol, so as not to impair the

absorption of the medicine.

Concomitant use of medicines from the

protease inhibitor group for the treatment

of AIDS and/or hepatitis C, together

with cholesterol-lowering medicines of

the statin group, may raise the level of

statins in the blood and thereby increase

the risk of muscle injury )myopathy(. The

most severe type of muscle injury, called

rhabdomyolysis, can cause kidney damage

and lead to kidney failure.

use of the medicine and food:

The medicine can be taken with or without

food, with half a glass of water.

Pregnancy and breastfeeding:

Do not use the medicine when you are

pregnant, planning to become pregnant or

breastfeeding. If you become pregnant during

the course of treatment with this medicine,

stop treatment with the medicine and refer to

a doctor immediately.

Driving and operating machinery:

Use of the medicine does not impair alertness,

but some patients may feel dizzy while taking

the medicine. Therefore, if you feel dizzy, have

blurred or double vision, consult the doctor

before driving a car, operating dangerous

machinery or engaging in any activity that

requires alertness.

use of the medicine and alcohol

consumption:

Do not drink a lot of wine and alcoholic

beverages during the course of treatment

with the medicine.

Important information about some of

the ingredients in this medicine:

Pravalip contains lactose and may cause an

allergic reaction in people sensitive to lactose.

If you have been told by the doctor that you

have an intolerance to certain sugars, refer to

the doctor before taking this medicine.

3. HOW

SHOulD

yOu

uSE

THE

MEDICINE?

Always use according to the doctor’s

instructions.

Check with the doctor or pharmacist if you are

uncertain about the dosage and treatment

regimen of the preparation.

The dosage and treatment regimen will be

determined by the doctor only.

Dosage:

According to the doctor’s instructions only.

Do not exceed the recommended dosage.

How to use the medicine:

The tablet can be swallowed before or after

food.

Swallow the medicine with half a glass of

water.

If necessary, the tablet can be halved for

immediate use. There is no information

regarding crushing or chewing of the tablet.

Use this medicine at set intervals, as

determined by the attending doctor.

Maintain a low-cholesterol diet during the

course of treatment with this medicine.

It is recommended to take the medicine in

the evening.

Take Pravalip at least one hour before

or four hours after taking resin-binding

medicines such as cholestyramine or

colestipol.

Abstain from eating grapefruit or drinking

grapefruit juice in large quantities.

Complete

t h e

t re a t m e n t

regimen

recommended by the doctor.

Even if there is an improvement in your

health, do not stop treatment with the

medicine without consulting with the doctor.

If you accidentally took a higher dosage,

or if a child has accidentally swallowed the

medicine, refer immediately to a doctor or

proceed to a hospital emergency room and

bring the package of the medicine with you.

If you forgot to take this medicine at the set

time, take a dose as soon as you remember,

but never take two doses together.

Do not take medicines in the dark! Check

the label and the dose each time you take

medicine. Wear glasses if you need them.

If you have further questions regarding

use of the medicine, consult the doctor

or pharmacist.

4. SIDE EFFECTS

As with any medicine, use of Pravalip may

cause side effects in some users. Do not be

alarmed by the list of side effects. You may not

suffer from any of them.

Stop treatment with the medicine and refer

to a doctor immediately if you are suffering

from any of the following side effects:

Side effects that may indicate impaired

liver function: fatigue or weakness, loss of

appetite, upper abdominal pain, dark yellow-

colored urine, increased blood bilirubin

levels, yellowing of the skin and eyes. If no

other factor that may have led to impaired

liver function )aside from use of Pravalip(

is found, do not resume the treatment.

Unexplained muscle pain, tenderness or

weakness, or muscle cramps, especially

if accompanied by high fever and a

general unwell feeling. In very rare cases,

muscle problems may be more serious

)rhabdomyolysis( and may lead to kidney

disease that can be life-threatening.

Hypersensitivity reactions )angioneurotic

edema, anaphylaxis(, severe allergic

reaction, including swelling of the face, lips,

tongue, breathing and swallowing difficulties

)very rare(.

Uncommon side effects )occur in up to 1

in 1,000 patients(:

Dizziness,

fatigue,

headache,

sleep

disturbances, including insomnia.

Blurred or double vision.

Indigestion, such as nausea, vomiting,

abdominal pain or discomfort, diarrhea or

constipation, flatulence.

Skin allergy )hives(, pimples, itching, rash,

scalp and hair problems )including hair

loss(.

Bladder-related problems, e.g., pain,

frequent urination, need for urination at

night.

Sexual dysfunction.

Muscle and joint pains.

Very rare side effects )occur in up to 1 in

10,000 patients(:

Nervous system problems, including:

problems with touch – burning sensation,

problems with the skin, including a tingling

and numb sensation of the skin, which may

indicate neural damage.

Severe skin disease )lupus erythematosus-

like syndrome(.

Inflammation of the liver or pancreas,

jaundice )yellowing of the skin and eyes(,

rapid death of liver cells )fulminant hepatic

necrosis(.

Increase in liver enzymes appearing in

a blood test, which can be a sign of liver

problems. The doctor may perform periodic

tests to monitor the condition.

Muscle inflammation, muscle pain or

weakness, tendon inflammation that may

lead to tendon rupture.

Side effects occurring at an unknown

frequency:

Breathing problems, including bothersome

cough and/or shortness of breath or fever.

Fever.

Nightmares.

Depression.

Diabetes – use of medicines from the statin

group may cause an increase in blood sugar

levels. If you are diabetic or are at risk of

diabetes )if you have high blood fat and

sugar levels, are overweight or have high

blood pressure(, you must be under medical

surveillance during the course of treatment.

Forgetfulness/memory loss, confusion.

Muscle weakness that also persists after

discontinuing use of the medicine.

If a side effect occurs, if one of the side

effects worsens, or if you suffer from a

side effect not mentioned in the leaflet,

consult with the doctor.

Side

effects

reported

Ministry of Health by clicking on the link

“Report Side Effects of Drug Treatment”

found on the Ministry of Health homepage

)www.health.gov.il( that directs you to

the online form for reporting side effects.

Additionally, you can report to “Unipharm Ltd.”

5. HOW SHOulD THE MEDICINE BE

STORED?

Avoid poisoning! This medicine, and any

other medicine, should be kept in a safe place

out of the reach and sight of children and/or

infants in order to avoid poisoning.

Do not use the medicine after the expiry date

)exp. date( that appears on the package. The

expiry date refers to the last day of that month.

Storage: Store below 25°C and in a place

protected from light.

6. FuRTHER INFORMATION

In addition to the active ingredient, the

medicine also contains:

Microcrystalline

cellulose;

Lactose;

Magnesium oxide; Croscarmellose sodium;

Magnesium stearate.

What the medicine looks like and the contents

of the package:

Pravalip 10, 20:

A round, white, biconvex tablet, with a score

line on one side.

Pravalip 40:

An oblong, white tablet, with a score line on

one side.

The tablets are packaged in trays )blisters(,

which are inserted into a carton package.

Each Pravalip pack has 10, 20, 28 or 30

tablets.

Not all package sizes may be marketed.

Registration holder and address: Unipharm

Ltd., P.O. Box 21429, Tel Aviv, 6121301.

Manufacturer and address: Unipharm Ltd.,

“Mevo Carmel” Industrial Park.

The format of this March 2020 leaflet was

determined by the Ministry of Health and

its content aligns with the original product

leaflet which was checked and approved by

the Ministry of Health in March 2016.

Registration numbers of the medicine in

the National Drug Registry of the Ministry

of Health:

Pravalip 10: 132 80 31134 01

Pravalip 20: 132 79 31135 01

Pravalip 40: 132 78 31136 01

ةيمح ىلع صرحلا بجي ءاودلا اذهب جلاعلا ةرتف للاخ .لورتسلوكلاب ةريقف ةيئاذغ .ءاسملا يف ءاودلا لوانتب ىصوي تاعاس عبرأ وأ لبق ةعاس لقلأا ىلع پيلاڤارپ لوانت بجي نيماريتسيلوك لثم نيزيرلا تاطبار عون نم ةيودأ لوانت دعب .لوﭙيتسيلوك وأ ريصع برش نع وأ تورف پيرﭽلا لكأ نع عانتملإا بجي .ةريبك تايمكب تورف پيرﭽلا .بيبطلا لبق نم هب تيصوأ امك جلاعلا لامكإ كيلع ،بيبطلا ةراشتسإ نودب ءاودلاب جلاعلا نع فقوتلا زوجي لا

.ةيحصلا كتلاح ىلع نسحت أرط ولو ىتح أطخلاب لفط علب اذإ وأ ربكأ

ً

ايئاود

ً

ارادقم أطخلاب تلوانت اذإ يف ئراوطلا ةفرغل وأ بيبطلا ىلإ لاحلا يف هجوت ،ءاودلا نم .ءاودلا ةبلع كعم رضحأو ىفشتسملا لوانت بجي ،ددحملا تقولا يف ءاودلا اذه لوانت تيسن اذإ لاوحلأا نم لاح يأب زوجي لا نكلو ،كركذت لاح ةيئاود ةعرج .ةيوس نيتعرج لوانت عباط صيخشت بجي ! ةمتعلا يف ةيودلأا لوانت زوجي لا اهيف لوانتت

ةرم لك

يف يئاودلا رادقملا نم دكأتلاو ءاودلا . كلذ رملأا مزل اذإ ةيبطلا تاراظنلا عض . ءاود ،ءاودلا لامعتسإ لوح ةيفاضإ ةلئسأ كيدل ترفوت اذإ .يلديصلا وأ بيبطلا رشتسإ ةيبناجلا ضارعلأا )4 ةيبناج

اضارعأ ببسي دق پيلاڤارپ لامعتسإ نإ ،ءاود لكب امك .ةيبناجلا ضارعلأا ةمئاق نم شهدنت لا .نيلمعتسملا ضعب دنع .اهنم

ايأ يناعت لاأ زئاجلا نم ىلإ لاحلا يف هجوتلاو ءاودلا لامعتسإ نع فقوتلا بجي :ةيلاتلا ةيبناجلا ضارعلأا ىدحإ نم يناعت تنك اذإ بيبطلا فئاظو للاتخإ ىلع لدت نأ اهنأش نم يتلا ةيبناجلا ضارعلأا ىلعأ يف ملأ ،ماعطلل ةيهشلا نادقف ،فعض وأ قاهرإ :دبكلا نيبوريليبلا بسن عافترإ ،نكاد رفصأ نولب لوب ،نطبلا رخآ ببسم دجوي مل اذإ .نينيعلاو دلجلا رارفصإ ،مدلا يف للاتخلإ يدؤي نأ هنأش نم يذلا )پيلاڤارپ لامعتسإ ادع( .جلاعلا ديدجت زوجي لاف ،دبكلا فئاظو وأ ببسلا ةلوهجم تلاضعلا يف فعض وأ ةيساسح ،ملأ

ةرارحلا عافترإب ةقفارتم ترهظ اذإ ةصاخ ،ةيلضع تاصلقت لكاشملا نوكت دق ،

ادج ةردان تلااح يف .يندتم ماع روعشو دقو )ةططخملا تلاضعلا للاحنإ(

ادج ةريطخ ةيلضعلا .ةايحلا ىلع

ارطخ لكشي دق يذلا ىلكلا يف ضرمل يدؤت در ،ةيبصع ةيئاعو ةمذو( ةيساسحلا طرف نم لعف دودر

هجولا خافتنإ لمشي ديدش يسسحت لعف در ،)يفادهتسإ لعف

ادج ردان( علبلاو سفنتلا يف تابوعص ،ناسللا ،نيتفشلا نيب نم 1 ىتح ىدل رهظت( ةعئاش ريغ ةيبناج ضارعأ :)جلاعتم 1,000 .قرأ لمشت مونلا يف تابارطضإ ،عادص ،قاهرإ ،راود .ةيؤرلا جاودزإ وأ ةيؤرلا شوشت يف جاعزنإ وأ ملأ ،ؤيقت ،نايثغ لثم مضهلا يف تابوعص .ةخفن ،كاسمإ وأ لاهسإ ،نطبلا ةورف يف لكاشم ،حفط ،ةكح ،روثب ،)ىرش( يدلج سسحت .)رعشلا طقاست لمشت( رعشلاو سأرلا ةجاحلا ،لوبتلا راركت ،ملأ لثم ةيلوبلا ةناثملاب ةقلعتم لكاشم .ليللا يف لوبتلل .يسنجلا ءادلأا يف تابارطضإ .لصافملا يفو تلاضعلا يف ملاآ نيب نم 1 ىتح ىدل رهظت(

ً

ادج ةردان ةيبناج ضارعأ :)جلاعتم 10,000 ـ سمللا يف لكاشم :لمشت ،يبصعلا زاهجلا يف لكاشم لمنتو زخوب روعشلا لمشت ةيدلج لكاشم ،قرحب روعشلا .ةيبصع ةباصإ ىلع لدت نأ نكمي يتلا دلجلا يف lupus( ءارمحلا ةبئذلا هبشت ةمزلاتم( ديدش يدلج ضرم

.)erythematous-like syndrome

،)نينيعلاو دلجلا رارفصإ( ناقري ،سايركنبلا وأ دبكلا باهتلإ

.)جئاه يدبك رخن( دبكلا ايلاخل عيرس توم يذلاو ،مدلا صوحف يف رهظي يذلا دبكلا تاميزنإ عافترإ زئاجلا نم .دبكلا يف لكاشم دوجول ةملاع لكشي نأ نكمي .عضولا ةبقارمل ةيرود صوحف ءارجإب بيبطلا موقي نأ راتولأا باهتلإ ،تلاضعلا يف فعض وأ ملأ ،لضعلا باهتلإ .رتولا قزمت ىلا يدؤي دق يذلا :ةفورعم ريغ ةريتوب رهظت ةيبناج ضارعأ سفنت قيض وأ/و جعزم لاعس لمشت ،سفنتلا يف لكاشم .ةنوخس وأ .ةنوخس .ةيليل سيباوك .بائتكإ تانيتاتسلا ةعومجم نم ةيودأ لامعتسإ نإ ـ يركسلا ءاد

اضيرم تنك اذإ .مدلا يف ركسلا بسن عافترلإ يدؤي دق تناك اذإ( يركسلاب ةباصلإا ةروطخل

اضرعم وأ يركسلاب نزو كيدل ،مدلا يف ركسلاو موحشلا نم ةيلاع بسن كيدل ةبقارملا تحت نوكت نأ كيلعف )عفترم مد طغض وأ دئاز .جلاعلا ةرتف للاخ ةيبطلا .كابترإ ،ةركاذلا نادقف/نايسن لوانت نع فقوتلا دعب

اضيأ رمتسي يذلا يلضع فعض .ءاودلا ضارعلأا ىدحإ تمقافت اذإ ،يبناج ضرع رهظ اذإ يف ركذي مل يبناج ضرع نم يناعت امدنع وأ ،ةيبناجلا .بيبطلا ةراشتسإ كيلع ،ةرشنلا هذه ةطساوب ةحصلا ةرازول ةيبناج ضارعأ نع غيلبتلا ناكملإاب جلاع بقع ةيبناج ضارعأ نع غيلبت« طبارلا ىلع طغضلا ةرازو عقومل ةيسيئرلا ةحفصلا ىلع دوجوملا »يئاود جذومنلا ىلإ كهجوي يذلا )www.health.gov.il(ةحصلا ناكملإاب ،كلذل ةفاضلإاب .ةيبناج ضارعأ نع غيلبتلل رشابملا ."ض.م مرافينوي" ةكرش غيلبت ؟ءاودلا نيزخت ةيفيك )5 يف رخآ ءاود لكو ءاودلا اذه ظفح بجي ! ممستلا بنجت لافطلأا ةيؤر لاجمو يديأ لوانتم نع

اديعب قلغم ناكم . ممستلاب مهتباصإ يدافتل كلذو ،عضرلا وأ/و ةيحلاصلا خيرات ءاضقنإ دعب ءاودلا لامعتسإ زوجي لا خيرات ريشي .ةبلعلا رهظ ىلع رهظي يذلا )exp date( .رهشلا سفن نم ريخلأا مويلا ىلإ ةيحلاصلا ءاضقنإ ناكم يفو ةيوئم ةجرد 25 نود نيزختلا بجي :نيزختلا .ءوضلا نم يمحم ةيفاضإ تامولعم )6

اضيأ ةلاعفلا ةداملل ةفاضلإاب ءاودلا يوتحي

Microcrystalline cellulose; Lactose;

Magnesium oxide; Croscarmellose sodium;

Magnesium stearate.

:ةبلعلا ىوتحم وه امو ءاودلا ودبي فيك :20 ،10 پيلاڤارپ رطشلل طخ وذ نيبناجلا لاك نم بدحم ،ريدتسم ،ضيبأ صرق .دحاو بناج نم :40 پيلاڤارپ .دحاو بناج نم رطشلل طخ وذ ،لواطم ،ضيبأ صرق .نوترك ةبلع لخاد )رتسيلب( تاحيول نمض ةأبعم صارقلأا

اصرق 30 وأ 28 ،20 ،10 دجوي پيلاڤارپ ةبلع لك يف .بلعلا ماجحأ ةفاك ق

وست لاأ زئاجلا نم :هناونعو زايتملإا بحاص مسإ .6121301 ،بيبأ ـ لت ،21429 .ب.ص ،.ض.م مرافينوي :هناونعو جتنملا مسإ ."لمرك وڤام" ةعانصلا كراپ ،.ض.م مرافينوي ترقأ يتلا ةغيصلا قفو يه 2020 راذآ خيرات نم ةرشنلا هذه رضحتسملا ةرشنل قباطم اهاوتحمو ةحصلا ةرازو لبق نم خيراتب ةحصلا ةرازو لبق نم تصخرو تصحف يتلا يلصلأا .2016 راذآ ةرازو يف يموكحلا ةيودلأا لجس يف ءاودلا لجس ماقرأ :ةحصلا 132 80 31134 01 :10 پيلاڤارپ 132 79 31135 01 :20 پيلاڤارپ 132 78 31136 01 :40 پيلاڤارپ ةغيصب ةرشنلا هذه ةغايص تمت ،ةءارقلا نيوهتو ةلوهس لجأ نم .نيسنجلا لاكل صصخم ءاودلا نإف ،كلذ نم مغرلا ىلع .ركذملا

סמ סמ

Pra10,20&40-21

Pra10,20&40-21

העדוה העדוה

לע לע

הרמחה הרמחה

(

(

עדימ עדימ

)תוחיטב )תוחיטב ךיראת

___

_____

20.03.2012

__________

םש

רישכת

_תילגנאב

Pravalip 10;20;40

רפסמ

םושיר

_

31134

31135

31136

םש

לעב

__םושירה

U nipharm Ltd

.

_____

םייונישה

ןולעב

םינמוסמ

לע

עקר

בוהצ ןכרצל ןולעב ןכרצל ןולעב קרפ

ןולעב תובוגת

ןיב תויתפורת םא

ךניה

ת/לטונ

הפורת

תפסונ

וא

םא תמייס

הז

התע

לופיטה

הפורתב

,תרחא ללוכ

תופורת

אלל

םשרמ

יפסותו

,הנוזת ךילע

חוודל

אפורל

לפטמה

ידכ

עונמל םינוכיס

וא

תוליעי-יא

םיעבונה

תובוגתמ

ןיב דחוימב ,תויתפורת

יבגל

תופורת

תוצובקהמ תופורת :תואבה

יוכידל

תכרעמה

תינוסיחה ןוגכ(

תופורת ,)ןירופסולקיצ

תדרוהל

תמר לורטסלוכה

תצובקמ

םיטרביפה

תופורתו דגנ

תשירק

םד

טעמל(

.)ןירפרוו םא

ךניה

ת/לטונ

הפורת

תפסונ

וא

םא תמייס

הז

התע

לופיטה

הפורתב

,תרחא ללוכ

תופורת

אלל

םשרמ

יפסותו

,הנוזת ךילע

חוודל

אפורל

לפטמה

ידכ

עונמל םינוכיס

וא

תוליעי-יא

םיעבונה

תובוגתמ

ןיב דחוימב ,תויתפורת

יבגל

תופורת

תוצובקהמ תופורת :תואבה

יוכידל

תכרעמה

תינוסיחה ןוגכ(

תופורת ,)ןירופסולקיצ

תדרוהל

תמר לורטסלוכה

תצובקמ

םיטרביפה

תופורתו דגנ

תשירק

םד

טעמל(

)ןירפרוו

,ריואנוטיר

ריואנורד ,ריואניפול לופיטל תופורת סדייאב

ובש ,ןולעה

םינמוסמ

םייונישה

םישקובמה

לע

עקר

בוהצ

רבעוה

ראודב

ינורטקלא

:ךיראתב

20.03.12

םייק

ןולע

אפורל

אוהו

ןכדועמ

.םאתהב אתכמסא

:השקבל םוסרפ

תעדוה

הרהזא

י"ע

תויושר

תואירב

ל"וחב

חקורה ,ינא

הנוממה

לש

תרבח

םראפינוא

מ"עב

ריהצמ

הזב

יכ

ןיא

םייוניש

םיפסונ .ןולעב

תמיתח

חקורה

הנוממה

Page 1 of 1

Similar products

Search alerts related to this product

View documents history

Share this information